Detalhe da pesquisa
1.
Novel phosphatidylinositol 4-kinases III beta (PI4KIIIß) inhibitors discovered by virtual screening using free energy models.
J Comput Aided Mol Des
; 34(10): 1091-1103, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32601839
2.
Novel furfurylidene N-acylhydrazones derived from natural safrole: discovery of LASSBio-1215, a new potent antiplatelet prototype.
J Enzyme Inhib Med Chem
; 27(1): 101-9, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21612374
3.
2-Arylpropionic Acid Pyrazolamides as Cannabinoid CB2 Receptor Inverse Agonists Endowed with Anti-Inflammatory Properties.
Pharmaceuticals (Basel)
; 15(12)2022 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36558970
4.
Identification of LASSBio-1945 as an inhibitor of SARS-CoV-2 main protease (MPRO) through in silico screening supported by molecular docking and a fragment-based pharmacophore model.
RSC Med Chem
; 12(1): 110-119, 2021 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34046603
5.
Synthesis and analgesic profile of conformationally constrained N-acylhydrazone analogues: discovery of novel N-arylideneamino quinazolin-4(3H)-one compounds derived from natural safrole.
Bioorg Med Chem
; 17(18): 6517-25, 2009 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19699644
6.
Beneficial effects of a novel agonist of the adenosine A2A receptor on monocrotaline-induced pulmonary hypertension in rats.
Br J Pharmacol
; 169(5): 953-62, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23530610